Miglyol®-812 neutral oil is a medium-chain triglyceride (MCT) oil derived from vegetable oils. It is composed of saturated fatty acids with 8 to 12 carbon atoms. Miglyol®-812 serves as a neutral, colorless, and odorless oil that can be used in various applications.
Amphotericin B (AmB) (99.8% purity) and Nicardipine Hydrochloride (98% purity), the internal standard (IS), were purchased from Sigma–Aldrich (St. Louis, MO, USA different types of Poly(d,l-lactide-co-glycolide) (Table 1) were supplied by Boehringer Ingelheim (Ingelheim, Germany). Miglyol®-812 neutral oil was obtained from Sasol (GmbH, Germany,). Vitamin E (TPGS-NF) grade was purchased from Peboc (Eastman, UK). Pluronic F68 Prilled was obtained from Ruger Chemical Co. Inc. (Irvington, New Jersey, USA). All other reagents and chemicals were HPLC analytical grade, and were used as received. Water was deionized and purified by a Milli-Q Reagent Grade water system from Millipore Corporation (Bedford, MX, USA).
Composition of the use pegylated PLGA–PEG copolymers types.
Symbol
Name
Polymer type
Composition
Lactic to glycolic acid ratio
Content of PEG (%)
Molecular weight (Dalton)
A
RGPd 50105
Diblock
PLGA–PEG 6000
1:1
10
5000
B
RGPt 50106
Triblock
PLGA–PEG 6000-PLGA
1:1
10
6000
C
RGPd 50155
Diblock
PLGA–PEG 6000
1:1
15
6000
D
RGPd 5055
Diblock
PLGA–PEG 6000
1:1
5
5000
E7
R 203 H
Monoblock
Poly(d,l-lactide)
–
–
18,000–28,000
AL-Quadeib B.T., Radwan M.A., Siller L., Horrocks B, & Wright M.C. (2014). Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization. Saudi Pharmaceutical Journal : SPJ, 23(3), 290-302.
Two tests of dissolution of approximately 550 mg of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-7β,10β-dimethoxy-9-oxotax-11-en-13α-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate in 14 g of Miglyol 812 Neutral oil, Sasol are carried out. Magnetic stirring is carried out at 500 rpm for 24 hours at ambient temperature.
After one week, the samples are vacuum-filtered and rinsed with heptane. Each sample is analysed by PXRD for confirmation of the form obtained. After filtration, between 300 and 350 mg of anhydrous form D are obtained.
US10160739B2. Crystalline forms of dimethoxy docetaxel and methods for preparing the same (2018-12-25). Aventis Pharma S.A. [FR]. Inventors: Pascal Billot [FR], Marielle Dufraigne [FR], Hagit Elmaleh [FR], Fabrice Mangin [FR], Patricia Rortais [FR], Lionel Zaske [FR], Alexandre Giuliani [FR].
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required